An artificial heart by French manufacturer Carmat
PARIS, July 19 - French artificial heartmaker CARMAT (ALCAR.PA) announced on Monday the first commercial implant of its Aeson artificial heart at a hospital in Italy, which the company said paved the way for its further commercial development.
Last week, CARMAT had announced the first human implant of its Aeson bioprosthetic artificial heart in the United States.
Reporting by Sudip Kar-Gupta
Pfizer: Know all about the Covid-19 vaccine and its usage in Qatar
FIFA’22 over Covid-19: Qatar limbers up for the World Cup amidst a worldwide pandemic
Top 5 Art Galleries You Must Explore in Qatar
Afghan Women Speaks on Unyielding Hope of Restoring Their Homeland